Amgen files Form 8-K for Oct. 26
Amgen’s Form 8-K was filed on October 27.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call
On Thursday, Ligand Pharmaceuticals (NASDAQ: LGND ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Full Transcri
AMG Files 8-K
Affiliated Managers Group submits matters to security holder vote. Routine filing.